Physician profile
Joanna Smith
NPI 1942718358
$3,762.74
in general payments reported to CMS, 2019-2025
16 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,555 · 2022: $639 · 2023: $940 · 2024: $135 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,568.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $669.75 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $611.71 | 2021-2025 | Rexulti, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $425.32 | 2021-2024 | Caplyta |
| Janssen Pharmaceuticals, INC | $352.22 | 2021-2025 | Spravato |
| Neurocrine Biosciences, INC. | $336.17 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $298.51 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $297.09 | 2021-2023 | Austedo Xr |
| Alkermes, INC. | $230.35 | 2022-2025 | Lybalvi, Aristada |
| Avanir Pharmaceuticals, INC. | $142.45 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $98.85 | 2021 | |
| Eisai INC. | $88.93 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.62 | 2021 | |
| Lundbeck LLC | $66.33 | 2021 | |
| Axsome Therapeutics, INC. | $41.30 | 2022-2023 | Auvelity |
| Sumitomo Pharma America, INC. | $18.81 | 2023 | Gemtesa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.